10-27155399-C-A

Variant summary

Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_001172303.3(MASTL):​c.-28C>A variant causes a 5 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.624 in 1,575,846 control chromosomes in the GnomAD database, including 309,884 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.60 ( 27801 hom., cov: 32)
Exomes 𝑓: 0.63 ( 282083 hom. )

Consequence

MASTL
NM_001172303.3 5_prime_UTR

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:4

Conservation

PhyloP100: 0.224
Variant links:
Genes affected
MASTL (HGNC:19042): (microtubule associated serine/threonine kinase like) This gene encodes a microtubule-associated serine/threonine kinase. Mutations at this locus have been associated with autosomal dominant thrombocytopenia, also known as thrombocytopenia-2. Alternatively spliced transcript variants have been described for this locus. [provided by RefSeq, Feb 2010]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.74).
BP6
Variant 10-27155399-C-A is Benign according to our data. Variant chr10-27155399-C-A is described in ClinVar as [Benign]. Clinvar id is 262113.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.643 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
MASTLNM_001172303.3 linkuse as main transcriptc.-28C>A 5_prime_UTR_variant 1/12 ENST00000375940.9

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
MASTLENST00000375940.9 linkuse as main transcriptc.-28C>A 5_prime_UTR_variant 1/121 NM_001172303.3 P5Q96GX5-1
MASTLENST00000375946.8 linkuse as main transcriptc.-28C>A 5_prime_UTR_variant 1/121 A1Q96GX5-3
MASTLENST00000342386.10 linkuse as main transcriptc.-28C>A 5_prime_UTR_variant 1/112 Q96GX5-2

Frequencies

GnomAD3 genomes
AF:
0.602
AC:
91400
AN:
151786
Hom.:
27804
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.557
Gnomad AMI
AF:
0.622
Gnomad AMR
AF:
0.570
Gnomad ASJ
AF:
0.629
Gnomad EAS
AF:
0.427
Gnomad SAS
AF:
0.477
Gnomad FIN
AF:
0.662
Gnomad MID
AF:
0.583
Gnomad NFE
AF:
0.648
Gnomad OTH
AF:
0.592
GnomAD3 exomes
AF:
0.592
AC:
115272
AN:
194594
Hom.:
34644
AF XY:
0.590
AC XY:
62832
AN XY:
106548
show subpopulations
Gnomad AFR exome
AF:
0.554
Gnomad AMR exome
AF:
0.541
Gnomad ASJ exome
AF:
0.616
Gnomad EAS exome
AF:
0.441
Gnomad SAS exome
AF:
0.488
Gnomad FIN exome
AF:
0.670
Gnomad NFE exome
AF:
0.653
Gnomad OTH exome
AF:
0.625
GnomAD4 exome
AF:
0.626
AC:
891481
AN:
1423946
Hom.:
282083
Cov.:
33
AF XY:
0.623
AC XY:
439517
AN XY:
705682
show subpopulations
Gnomad4 AFR exome
AF:
0.559
Gnomad4 AMR exome
AF:
0.541
Gnomad4 ASJ exome
AF:
0.620
Gnomad4 EAS exome
AF:
0.399
Gnomad4 SAS exome
AF:
0.492
Gnomad4 FIN exome
AF:
0.663
Gnomad4 NFE exome
AF:
0.648
Gnomad4 OTH exome
AF:
0.612
GnomAD4 genome
AF:
0.602
AC:
91406
AN:
151900
Hom.:
27801
Cov.:
32
AF XY:
0.601
AC XY:
44600
AN XY:
74238
show subpopulations
Gnomad4 AFR
AF:
0.556
Gnomad4 AMR
AF:
0.570
Gnomad4 ASJ
AF:
0.629
Gnomad4 EAS
AF:
0.426
Gnomad4 SAS
AF:
0.479
Gnomad4 FIN
AF:
0.662
Gnomad4 NFE
AF:
0.648
Gnomad4 OTH
AF:
0.585
Alfa
AF:
0.628
Hom.:
5507
Bravo
AF:
0.594
Asia WGS
AF:
0.445
AC:
1549
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
Benign, criteria provided, single submitternot providedBreakthrough Genomics, Breakthrough Genomics-- -
Benign, criteria provided, single submitterclinical testingGeneDxJun 19, 2021- -
not specified Benign:1
Benign, criteria provided, single submitterclinical testingPreventionGenetics, part of Exact Sciences-- -
Thrombocytopenia Benign:1
Benign, criteria provided, single submitterclinical testingIllumina Laboratory Services, IlluminaJan 13, 2018This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.74
CADD
Benign
8.0
DANN
Benign
0.72
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.0

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs7919803; hg19: chr10-27444328; COSMIC: COSV58759031; COSMIC: COSV58759031; API